This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
other
product name :
Cultrex 3D Culture Matrix Laminin I
catalog :
3446-005-01
quantity :
30 mg
price :
907 USD
citations: 14
| Reference |
|---|
product information
master code :
3446-005-01
SKU :
3446-005-01
product name :
Cultrex 3D Culture Matrix Laminin I
unit size :
30 mg
target :
Laminin-1
category :
Cell Culture Products
buffer :
6 mg/ml
species :
Multi-Species
details of functionality :
Functional Assays: 3-D Culture - Laminin I promotes differentiation of a human epithelial cell line derived from mammary gland (MCF-10A) into acinar structures. Cell Attachment - Tested for the ability to promote cell attachment and spreading of MG63 human osteosarcoma cells.
endotoxin note :
<20.0 EU per 1 ╡g of the protein by the LAL method.
applications :
Bioactivity
USD :
907 USD
alt names :
LAMA, LAMA1, laminin subunit alpha 1, Laminin1, Laminin-111, PTBHS, S-LAM-alpha
storage :
Product is stable for a minimum of 3 months from date of shipment when stored at -80 ░C in a manual defrost freezer. For optimal stability, store at -80 ░C in aliquots. Avoid repeated freeze/thaw cycles. Storage Buffer: DulbeccoÆs Modified EagleÆs medium containing 10 ╡g/ml gentamycin sulfate and no phenol red. Sterility Testing: No bacterial or fungal growth detected after incubation at 37 ░C for 14 days following USP XXIV Chapter 71 sterility test. No mycoplasma contamination detected by PCR.
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
questions and comments
